XLS.SW Stock — Price, Charts & Analysis

Xlife Sciences AG (XLS.SW) has no trailing P/E shown and a forward P/E of -5.17x. This places XLS.SW in not enough valuation data territory based on the valuation data currently available on Worldtickers.

XLS.SW trades with -5.17x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether XLS.SW looks overvalued or undervalued.

XLS.SW's P/E of -5.17x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

XLS.SW's trailing EPS is -CHF 3.76 and forward EPS is -CHF 2.94.

EPS, or earnings per share, shows how much profit Xlife Sciences AG generated for each share. XLS.SW's trailing EPS is -CHF 3.76, and investors usually prefer EPS that is positive and growing over time.

Xlife Sciences AG has a market cap of CHF 87.67M, making XLS.SW a small-cap stock based on the current market value shown on Worldtickers.

XLS.SW's latest stock price on Worldtickers is CHF 15.20. The latest move is CHF 0.10 or 0.66%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

XLS.SW's quote includes a latest price of CHF 15.20. The market open is CHF 15.20. Previous close is CHF 15.10. The intraday range is CHF 15.20 to CHF 15.20.

XLS.SW is up in the latest quote, with a move of CHF 0.10 or 0.66%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

XLS.SW generated CHF 275.31K in trailing revenue.

No, XLS.SW does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -CHF 21.55M.

Gross margin is 3.39%. Margins show how efficiently Xlife Sciences AG turns revenue into profit.

Xlife Sciences AG carries CHF 60.57M and holds CHF 1.05M in cash.

XLS.SW holds CHF 1.05M on its balance sheet.

XLS.SW's book value per share is CHF 52.84.

Institutions hold 5.23% of XLS.SW shares. Insiders hold 48.49% of shares. Ownership mix helps investors understand how much of Xlife Sciences AG is held by professional investors and company insiders.

XLS.SW has 5.77M shares outstanding. Float shares are 2.84M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for XLS.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for XLS.SW is -CHF 2.94. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

XLS.SW's trailing EPS is -CHF 3.76. Forward EPS is -CHF 2.94. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

XLS.SW is in the Healthcare sector. Its earnings multiple is -5.17x. Compare these figures with sector peers before deciding whether Xlife Sciences AG is stronger or weaker than average.

XLS.SW trades at CHF 15.20. The stock trades at -5.17x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Xlife Sciences AG's fundamentals.

XLS.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.44, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

XLS.SW should be compared with companies in Biotechnology. Its earnings multiple is -5.17x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Xlife Sciences AG (XLS.SW) operates in Healthcare, specifically Biotechnology. Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company's project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas; focuses in the areas of medic

XLS.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

XLS.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Xlife Sciences AG's official website listed on Worldtickers is www.xlifesciences.ch. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Xlife Sciences AG employs about 20 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Xlife Sciences AG is headquartered in Zurich, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

XLS.SW is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

XLS.SW has traded between CHF 15.10 and CHF 26.80 over the past 52 weeks. At CHF 15.20, it is 43.28% below the high and 0.66% above the low. The 52-week range helps gauge long-term price momentum.

XLS.SW is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is CHF 18.26 and its 200-day moving average is CHF 20.84.

XLS.SW's RSI is 34.39. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

XLS.SW's latest RSI reading is 34.39, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for XLS.SW is near CHF 15.10. Key resistance is near CHF 17.05. Breaks above resistance or below support can change the short-term technical setup.

XLS.SW's nearest reported support level is CHF 15.10. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

XLS.SW's nearest reported resistance level is CHF 17.05. A breakout above resistance can improve momentum, especially when volume confirms the move.

XLS.SW trades about 8.58K shares daily on average. The latest displayed volume is 313 shares. Volume helps show liquidity and whether trading interest is unusually high or low.

XLS.SW's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

XLS.SW is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 34.39 (neutral). MACD is bullish. Nearest support is around CHF 15.10. Resistance is around CHF 17.05. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 16.15 (-5.85% from price). MA50 is CHF 18.26 (-16.76% from price). MA200 is CHF 20.84 (-27.05% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. XLS.SW's MA20 is CHF 16.15. MA50 is CHF 18.26. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

XLS.SW's pivot is near CHF 15.27. Support is near CHF 15.10. Resistance is near CHF 17.05. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next upper resistance zone is near CHF 16.43. These levels help define risk and possible follow-through zones after a breakout or breakdown.

XLS.SW's Bollinger range is roughly CHF 15.07 to CHF 17.22. Band width is near 13.32%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

XLS.SW's ATR-based typical daily range is about 3.88%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 313 shares. Average volume is about 8.58K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

XLS.SW's all-time high shown on Worldtickers is CHF 52.00. Its all-time low is CHF 15.10. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

XLS.SW has a beta of 0.44, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.